Slide 1: Faster, more accurate gold analysis
For personal use only Faster, more accurate gold analysis Q4 FY23 - Quarterly Investor Update 27 July 2023 Dirk Treasure, Managing Director and CEO Brett Coventry, CFO
Slide 2: Important notice
Important notice For personal use only The material in this presentation has been prepared by Chrysos Corporation Limited (ASX: C79) (“Chrysos” or the “Group") and is general background information about Chrysos’ current activities as at the date of this presentation. The information is given in sum
Slide 3: Financial and operating highlights
Financial and operating highlights Q4 FY23 Unaudited Total Revenue of $8.6m, reflecting 27% growth on the previous Quarter For personal use only $8.6m 978k $702m Total Unaudited Q4 FY23 Revenue Samples processed Total Contract Value (TCV) • +27% growth on Q3 FY23 ($6.7m) • Increased 20% on Q3 FY23 (
Slide 4: Top line momentum continuing
Top line momentum continuing Two new unit deployments in Q4 FY23 and consistent Additional Assay Charges driving revenue growth For personal use only Unaudited MMAP, AAC & Other Income ■ Minimum Monthly Assay Payments (MMAP) provide predictable Quarterly and sustainable minimum revenue MMAP, Adition
Slide 5: Executing on our global PhotonAssay roll out
Executing on our global PhotonAssayTM roll out Strong and sustainable growth underpinned by long-term annuity-style recurring revenue For personal use only 20 Units Deployed1 Average Unit Utilisation & Samples Processed 400,000 80% 350,000 70% Number of PhotonAssays 300,000 60% 250,000 50% Utilisati
Slide 6: Strong sales pipeline ahead
Strong sales pipeline ahead Continued adoption of PhotonAssayTM by global laboratories and miners For personal use only Example Customers Total Contract Value1, 2 (Retiring metric) Intertek MSALABS ALS Total Contract Value #039;M's 1 800 700 Britannia Mining Solutions 600 500 Laboratories Alfred H Knig
Slide 7: FY24 Guidance
FY24 Guidance Forecastable revenue model provides reliable visibility For personal use only FY24 Guidance: ■ FY24 Total Revenue range of $48m to $58m, an increase of almost 100% at the midpoint ■ Based on MMAP from installed units and 18 units scheduled for deployment during FY24 ■ No provision for
Slide 8: In summary
In summary Chrysos PhotonAssayTM rollout continues to gather momentum For personal use only ■ Continued top line growth in Q4 FY23: ■ 27% QoQ increase in Unaudited Total Revenue1 ■ 18% QoQ increase in Minimum Monthly Assay Payments ■ FY23 Prospectus targets for Revenue and EBITDA achieved on an unau
Slide 9: About Chrysos
For personal use only About Chrysos [Insert]
Slide 10: Chrysos – revolutionising the global mining industry
Chrysos – revolutionising the global mining industry Chrysos is a global provider of novel assay services through its proprietary PhotonAssayTM technology For personal use only Disruptive Minerals Analysis Service and Lease Model with Industry Accepted Technology Technology Tier 1 Counterparties Dis
Slide 11: Our commercialisation journey
Our commercialisation journey The outcome of 20+ years of research and development For personal use only Prototype Complete JORC and NI43-101 New Customer Announcements 1st PhotonAssayTM Max unit Companies cite PhotonAssayTM data Barrick Bulyanhulu in Tanzania contracts in market announcements MSALA
Slide 12: The Chrysos Vision
The Chrysos Vision To become the world’s leading provider of innovative assay services and technologies For personal use only Market Challenge: Traditional assay techniques are slow, labour intensive, complex, destructive to the assay sample, and involve Fully-quantitative analysis in as little as 2
Slide 13: PhotonAssay technology
PhotonAssayTM technology Best in class gold assaying with measurable benefits over traditionally used methods For personal use only PhotonAssayTM vs. Traditional Fire Assay1 PhotonAssayTM value proposition Fire Assay PhotonAssayTM Faster turnaround Lower costs Simple to operate Results in as little
Slide 14: Large & unpenetrated TAM
Large & unpenetrated TAM Assay expenditure is a non-discretionary operating cost For personal use only Existing PhotonAssayTM Reach TAM for PhotonAssayTM Units 700 610 Units 600 500 PhotonAssayTM Unit 410 On-site 400 Laboratories +561 Units Units 300 200 Offices & manufacturing Off-site 100 200 Labo
Slide 15: Delivering tangible benefits for miners
Delivering tangible benefits for miners PhotonAssayTM enables timely decision making and additional gold recovery For personal use only The opportunity… PhotonAssayTM is embedded in the mining value chain PhotonAssayTM Value Add ■ Each year global miners are Exploration Fast turnaround for mine esti
Slide 16: An environmentally-friendly solution
An environmentally-friendly solution Substantially better for the environment and significantly safer than fire assay For personal use only PhotonAssayTM has a substantial positive environmental impact that will continue to grow in tandem with the uptake of the technology PhotonAssayTM reduces CO2
Slide 17: High barriers to entry
High barriers to entry High barriers to entry supported by global IP rights For personal use only Barriers to competitive entry Long-term leases with Protected by global guaranteed minimums, IP rights embedded at customer site 20+ years of R&D and Superior product to the investment in technology alt
Slide 18: Clear growth pathway
Clear growth pathway Clear organic growth plan with potential to expand TAM through additional commodities Business development pipeline For personal use only ■ A growing global network of laboratory leases Growth Trajectory for Installed Units (cumulative) BMS Intertek ALS SGS AHK MSALABS ■ PhotonA
Slide 19: Experienced leadership team
Experienced leadership team Supported by a well respected and tenured board For personal use only Senior leadership team Board of Directors Dirk Treasure Rob Adamson Kerry Gleeson Founding CEO & Managing Director Founder & Chairman Director • Metallurgist with a background in both • 20+ years’ exper
Slide 20: Thank you
Thank you For personal use only For more information, please visit chrysoscorp.com or contact us at investors@chrysoscorp.com